期刊文献+

绝经后阴道出血650例临床病理分析 被引量:1

Clinicopathologic analysis of 650 colponhagia cases post menopause
下载PDF
导出
摘要 目的 :探讨绝经后阴道出血 (PMB)的临床病理特点、病因及发病机理。方法 :全面分析PMB患者的临床资料及病理资料 ,所有患者均经诊断性刮宫或宫颈活组织检查。结果 :良性病变 5 17例 ,占 79 5 % ;恶性病变 94例 ,占 14 5 % (其中子宫内膜癌 5 9例 ,占恶性病变的 62 8% ) ;不典型增生 3 9例 ,占 6 0 %。宫颈病变引起出血 3 2 4例 ,占 49 8% ;宫体病变 3 0 6例 ,占 47 1% ;卵巢病变 2 0例 ,占 3 1%。结论 :PMB的病因主要是良性病变 ,但恶性肿瘤尤其是子宫内膜癌仍然是绝经后阴道出血的重要病因之一。PMB的病理类型与发病年龄及出血距绝经的年限有关 ,与出血量无明显关系。出血量的多少 ,在良、恶性病变中无显著差异。因此对年龄大、绝经年限长的阴道出血患者不论出血量多少都应高度重视 ,尽早进行病理检查 ,明确诊断 ,及时治疗。 Objective:To study the clinicopathologic characteristic ,pathogency and pathogenic mechanism of postmenopausal bleeding(PMB). Methods:The 650 cases with PMB were taken clinicopathologic analysis completely .For all of patients , diagnostic curettage,biopsy of cervix and pathologic examination have to do .Results:Among patients of the benign lesion are 517 cases(79.5%), the malignant leision are 94 cases(14.5%), 59 cases with PMB carcinoma of the endometrium account for 62.8% of malignant leision, atypical hyperplasia are 39 cases(6.0%), lesions of cervix cover 324 cases(49.8%), lesions of corpus uterus are 306 cases(47..1%), lesions of ovary are 20 cases (3.1%).Conclusion:the benign lesion is main pathogency of PMB, nevertheless carcinoma of the endometrium in mailgnant tumor is important cause of PMB. The pathologic type and pathogenic age of PMB relate to fixed number of years between bleeding and menopause,meanwhile it does not obviousely relate to amoumt of bleeding .There is not marked difference between benign and malignant .So in spite of much or little of amoumt of bleeding,must pay enough attention to colporrhagia patiengs who are more aged and with long yesrs of menopause. And must practice pathological examinations earlier,make clear its diagnosis and treat it in time.
出处 《中国妇幼保健》 CAS 北大核心 2005年第3期360-362,共3页 Maternal and Child Health Care of China
关键词 绝经后阴道出血 病理 病因 发病机理 诊断性刮宫 宫颈活组织检查 Menopause Coiporrhagia The benign lesion The malignant leision Clinicopathology
  • 相关文献

参考文献9

二级参考文献5

共引文献1058

同被引文献8

  • 1Kuroboshi H,Okubo T,Kitaya K et al.Interferon regulatory factor-1 expression in human uterine endometrial carcinoma.Gynecol Oncol,2003,91 (2):354~358
  • 2Siegel PM,Massague J.C ytostatic and apoptotic actions of TGF-beta in homeostasis and cancer.Nat Rev Cancer,2003,3 (11):807~821
  • 3Zhao H,Shiina H,Greene KL et al.CpG methylation at promoter site-140 inactivates TGFbeta2 receptor gene in prostate cancer.Cancer,2005,104 (1):44~52
  • 4McClatchey AI.Merlin and ERM proteins:unappreciated roles in cancer development? Nat Rev Cancer,2003,3 (11):877~883
  • 5Khanna C,Wan X,Bose S et al.The membrane -cytoskeleton linker ezrin is necessary for osteosarcoma metastasis Nat Med,2004,10 (2):182~186
  • 6Wick W,Grimmel C,Wild -Bode C et al.Ezrin -dependent promotion of glioma cell clonogenicity,motility,and invasion mediated by BCL-2 and transforming growth factor-beta2.J Neurosci,2001,21 (10):3360~3368
  • 7Karmakar S,Das C.Modulation of ezrin and E -cadherin expression by IL-1 beta and TGF-beta1 in human trophoblasts.J Reprod Immunol,2004,64 (1 -2):9~29
  • 8来茂德,黄智达,黄琼,陈俭.RER+结直肠癌组织转化生长因子βⅡ型受体的突变[J].中华病理学杂志,2004,33(1):6-10. 被引量:3

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部